|
|
|
|
|
|
|
|
|
|
|
|
|
28.08.26 - 15:06
|
Biosergen′s Rights Issue Oversubscribed (Cision)
|
|
|
Biosergen AB (publ) ("Biosergen" or the "Company") today announces the outcome of the rights issue of shares (the "Rights Issue") for which the subscription period ended on 26 August 2026. The final outcome shows that 58,905,204 shares have been subscribed for with support of subscription rights, corresponding to approximately 73.8 percent of the offered shares. In addition, applications have been received to subscribe for 62,693,744 shares without support of subscription rights, corresponding to approximately 78.5 percent of the offered shares. The outcome shows that the Rights Issue has...
|
|
|
|
|
|
|
|
|
|
|
28.08.26 - 14:21
|
AstraZeneca Buy (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca mit einem Kursziel von 17500 Pence auf "Buy" belassen. Die zusätzliche Gabe von TTR-Stabilisatoren habe dem Herzmittel Wainua in der CARDIO-TTRansform-Studie die ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
